Recent developments in the clinical activity of topoisomerase-1 inhibitors.
Kreditor
Max
M
Fink
Matthew
M
Hochster
Howard S
HS
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004261:DNA Replication / Q000187:drug effects; D004264:DNA Topoisomerases, Type I / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019772:Topotecan / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D019772:Topotecan; D004264:DNA Topoisomerases, Type I